BCL2 and cancer: c-MYC is a group of proto-oncogenes and regulator genes that encode transcription factors, whereas Bcl-2 is overexpressed in cancer cells and inhibits pro-apoptotic signals to enable cancer cells to survive in adverse conditions [26,27].